Jane Street Group LLC Has $22.18 Million Holdings in Haleon PLC Sponsored ADR $HLN

Key Points

• Jane Street Group LLC significantly increased its holdings in Haleon PLC, boosting their shares by 933.1% to a total of 2,155,716 shares, valued at approximately $22.18 million.
• Haleon announced a new semi-annual dividend of $0.0555 per share, increasing its previous dividend, which reflects a dividend yield of 190.0%.
• Wall Street analysts have mixed ratings for Haleon, with a consensus rating of "Moderate Buy" and varied price targets, suggesting differing outlooks on the company's future performance.

Jane Street Group LLC boosted its stake in shares of Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) by 933.1% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,155,716 shares of the company's stock after purchasing an additional 1,947,050 shares during the period. Jane Street Group LLC's holdings in Haleon were worth $22,182,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Synovus Financial Corp grew its position in Haleon by 202.9% during the first quarter. Synovus Financial Corp now owns 474,011 shares of the company's stock valued at $4,878,000 after purchasing an additional 317,544 shares in the last quarter. ICONIQ Capital LLC grew its position in Haleon by 17.4% during the first quarter. ICONIQ Capital LLC now owns 25,375 shares of the company's stock valued at $261,000 after purchasing an additional 3,769 shares in the last quarter. Northwestern Mutual Wealth Management Co. grew its position in Haleon by 1,004.6% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 207,843 shares of the company's stock worth $2,139,000 after acquiring an additional 189,027 shares in the last quarter. CW Advisors LLC bought a new stake in Haleon in the first quarter worth approximately $230,000. Finally, Capital Fund Management S.A. grew its position in Haleon by 100.0% in the first quarter. Capital Fund Management S.A. now owns 108,828 shares of the company's stock worth $1,120,000 after acquiring an additional 54,407 shares in the last quarter. 6.67% of the stock is owned by hedge funds and other institutional investors.

Haleon Stock Performance

Shares of NYSE HLN traded down $0.10 during trading hours on Tuesday, hitting $9.71. 7,435,346 shares of the stock were exchanged, compared to its average volume of 12,688,458. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.87 and a quick ratio of 0.63. The company's 50 day moving average is $9.83 and its 200 day moving average is $10.22. The firm has a market capitalization of $43.51 billion, a P/E ratio of 24.86, a P/E/G ratio of 2.89 and a beta of 0.23. Haleon PLC Sponsored ADR has a one year low of $8.86 and a one year high of $11.42.

Haleon Increases Dividend

The company also recently disclosed a semi-annual dividend, which will be paid on Thursday, September 18th. Investors of record on Friday, August 15th will be issued a dividend of $0.0555 per share. The ex-dividend date of this dividend is Friday, August 15th. This represents a dividend yield of 190.0%. This is an increase from Haleon's previous semi-annual dividend of $0.05. Haleon's payout ratio is currently 28.21%.

Wall Street Analysts Forecast Growth

Several research firms have commented on HLN. Morgan Stanley raised shares of Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 target price for the company in a research report on Friday, May 9th. Barclays reissued an "overweight" rating on shares of Haleon in a research report on Tuesday, May 6th. BNP Paribas raised shares of Haleon to a "strong-buy" rating in a research report on Tuesday, May 27th. Wall Street Zen downgraded shares of Haleon from a "buy" rating to a "hold" rating in a research report on Saturday, July 12th. Finally, BNP Paribas Exane raised shares of Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 target price for the company in a research report on Tuesday, May 27th. Two research analysts have rated the stock with a Strong Buy rating, three have given a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Haleon presently has an average rating of "Moderate Buy" and an average target price of $12.33.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.